secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001641172-25-026867
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Adam Chambers appointed to board of Shuttle Pharmaceuticals; principal of Bowery Consulting
--------------------------------------------------------------------------------

- Appointment effective September 8, 2025; no family relationships with other directors/officers.
- Chambers is principal of Bowery Consulting, lender under revolving loan (Feb 28, 2025) and consulting services (Mar 21, 2025).
- No other material interests in transactions required to be disclosed under Item 404(a).
- No arrangements or understandings under which he was appointed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225026867/0001641172-25-026867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225026867/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer